RSS-Feed abonnieren
DOI: 10.1055/s-0037-1608828
Biliary Obstruction: Endoscopic Approaches
Publikationsverlauf
Publikationsdatum:
14. Dezember 2017 (online)
![](https://www.thieme-connect.de/media/sir/201704/lookinside/thumbnails/10-1055-s-0037-1608828_001040-1.jpg)
Abstract
Painless jaundice is a harbinger of malignant biliary obstruction, with the majority of cases due to pancreatic adenocarcinoma. Despite advances in treatment, including improved surgical techniques and neoadjuvant (preoperative) chemotherapy, long-term survival from pancreatic cancer is rare. This lack of significant improvement in outcomes is believed to be due to multiple reasons, including the advanced stage at diagnosis and lack of an adequate biomarker for screening and early detection, prior to the onset of jaundice or epigastric pain. Close attention is required to select appropriate patients for preoperative biliary decompression, and to prevent morbid complications from biliary drainage procedures, such as pancreatitis and cholangitis. Use of small caliber plastic biliary stents during endoscopic retrograde cholangiopancreatography should be minimized, as metal stents have increased area for improved bile flow and a reduced risk of adverse events during neoadjuvant therapy. Efforts are underway by translational scientists, radiologists, oncologists, surgeons, and gastroenterologists to augment lifespan for our patients and to more readily treat this deadly disease. In this review, the authors discuss the rationale and techniques of endoscopic biliary intervention, mainly focusing on malignant biliary obstruction by pancreatic cancer.
-
References
- 1 Baron Sr TH, Davee T. Endoscopic management of benign bile duct strictures. Gastrointest Endosc Clin N Am 2013; 23 (02) 295-311
- 2 Cancer of the Pancreas - Cancer Stat Facts. Available at: https://seer.cancer.gov/statfacts/html/pancreas.html . Accessed March 1, 2017
- 3 Kalser MH, Ellenberg SS. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985; 120 (08) 899-903
- 4 Neoptolemos JP, Palmer DH, Ghaneh P. , et al; European Study Group for Pancreatic Cancer. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet 2017; 389 (10073): 1011-1024
- 5 Rosewicz S, Wiedenmann B. Pancreatic carcinoma. Lancet (London, England) 1997; 349 (9050): 485-489
- 6 Argani P, Iacobuzio-Donahue C, Ryu B. , et al. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res 2001; 7 (12) 3862-3868
- 7 Jenkinson C, Elliott VL, Evans A. , et al. Decreased serum thrombospondin-1 levels in pancreatic cancer patients up to 24 months prior to clinical diagnosis: association with diabetes mellitus. Clin Cancer Res 2016; 22 (07) 1734-1743
- 8 Yang J-Y, Sun Y-W, Liu D-J, Zhang J-F, Li J, Hua R. MicroRNAs in stool samples as potential screening biomarkers for pancreatic ductal adenocarcinoma cancer. Am J Cancer Res 2014; 4 (06) 663-673
- 9 Herreros-Villanueva M, Bujanda L. Glypican-1 in exosomes as biomarker for early detection of pancreatic cancer. Ann Transl Med 2016; 4 (04) 64
- 10 Canto MI, Hruban RH, Fishman EK. , et al; American Cancer of the Pancreas Screening (CAPS) Consortium. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 2012; 142 (04) 796-804 , quiz e14–e15
- 11 Evans DB, Varadhachary GR, Crane CH. , et al. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol 2008; 26 (21) 3496-3502
- 12 Varadhachary GR, Wolff RA, Crane CH. , et al. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol 2008; 26 (21) 3487-3495
- 13 van der Gaag NA, Rauws EA, van Eijck CH. , et al. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med 2010; 362 (02) 129-137
- 14 Wasan SM, Ross WA, Staerkel GA, Lee JH. Use of expandable metallic biliary stents in resectable pancreatic cancer. Am J Gastroenterol 2005; 100 (09) 2056-2061
- 15 Mullen JT, Lee JH, Gomez HF. , et al. Pancreaticoduodenectomy after placement of endobiliary metal stents. J Gastrointest Surg 2005; 9 (08) 1094-1104 , discussion 1104–1105
- 16 Lee JH, Krishna SG, Singh A. , et al. Comparison of the utility of covered metal stents versus uncovered metal stents in the management of malignant biliary strictures in 749 patients. Gastrointest Endosc 2013; 78 (02) 312-324
- 17 Tse F, Yuan Y, Moayyedi P, Leontiadis GI. Guidewire-assisted cannulation of the common bile duct for the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. Cochrane Database Syst Rev 2012; 12: CD009662
- 18 Liao W-C, Angsuwatcharakon P, Isayama H. , et al. International consensus recommendations for difficult biliary access. Gastrointest Endosc 2017; 85 (02) 295-304
- 19 Ito K, Fujita N, Noda Y. , et al. Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic duct guidewire placement for achieving selective biliary cannulation? A prospective randomized controlled trial. J Gastroenterol 2010; 45 (11) 1183-1191
- 20 Yasuda I, Isayama H, Bhatia V. Current situation of endoscopic biliary cannulation and salvage techniques for difficult cases: current strategies in Japan. Dig Endosc 2016; 28 (Suppl. 01) 62-69
- 21 Davee T, Garcia JA, Baron TH. Precut sphincterotomy for selective biliary duct cannulation during endoscopic retrograde cholangiopancreatography. Ann Gastroenterol 2012; 25 (04) 291-302
- 22 Buscaglia JM, Kalloo AN. Pancreatic sphincterotomy: technique, indications, and complications. World J Gastroenterol 2007; 13 (30) 4064-4071
- 23 Iwashita T, Doi S, Yasuda I. Endoscopic ultrasound-guided biliary drainage: a review. Clin J Gastroenterol 2014; 7 (02) 94-102
- 24 Dhir V, Bhandari S, Bapat M, Maydeo A. Comparison of EUS-guided rendezvous and precut papillotomy techniques for biliary access (with videos). Gastrointest Endosc 2012; 75 (02) 354-359
- 25 Chavalitdhamrong D, Draganov PV. Endoscopic ultrasound-guided biliary drainage. World J Gastroenterol 2012; 18 (06) 491-497
- 26 Levy MJ. Therapeutic endoscopic ultrasound for biliary and pancreatic disorders. Curr Gastroenterol Rep 2010; 12 (02) 141-149
- 27 Dhir V, Bhandari S, Bapat M, Joshi N, Vivekanandarajah S, Maydeo A. Comparison of transhepatic and extrahepatic routes for EUS-guided rendezvous procedure for distal CBD obstruction. United European Gastroenterol J 2013; 1 (02) 103-108
- 28 van Wagensveld BA, Coene PP, van Gulik TM, Rauws EA, Obertop H, Gouma DJ. Outcome of palliative biliary and gastric bypass surgery for pancreatic head carcinoma in 126 patients. Br J Surg 1997; 84 (10) 1402-1406
- 29 De Koning M, Moreels TG. Comparison of double-balloon and single-balloon enteroscope for therapeutic endoscopic retrograde cholangiography after Roux-en-Y small bowel surgery. BMC Gastroenterol 2016; 16 (01) 98
- 30 Inamdar S, Slattery E, Sejpal DV. , et al. Systematic review and meta-analysis of single-balloon enteroscopy-assisted ERCP in patients with surgically altered GI anatomy. Gastrointest Endosc 2015; 82 (01) 9-19
- 31 Khashab MA, Tariq A, Tariq U. , et al. Delayed and unsuccessful endoscopic retrograde cholangiopancreatography are associated with worse outcomes in patients with acute cholangitis. Clin Gastroenterol Hepatol 2012; 10 (10) 1157-1161